XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.healtheconomics.com/industry-news/will-we-ever-be-able-to-rein-in-healthcare-spending60%Hourly2015-11-30 14:23
https://www.healtheconomics.com/industry-news/fda-discusses-broader-use-of-rwe-with-industry-leaders60%Hourly2015-11-30 17:05
https://www.healtheconomics.com/industry-news/how-could-vbp-help-lower-high-rx-costs60%Hourly2015-11-30 13:26
https://www.healtheconomics.com/industry-news/who-really-deserves-credit-for-discovery-of-statistical-regression60%Hourly2017-06-19 03:01
https://www.healtheconomics.com/industry-news/novartis-to-pay-390m-over-pharmacy-kickbacks60%Hourly2015-11-25 17:14
https://www.healtheconomics.com/health-reform/does-citizenship-require-taking-responsibility-for-each-other60%Hourly2015-11-25 16:18
https://www.healtheconomics.com/comparative-effectiveness/icer-releases-final-report-on-pcsk9-use60%Hourly2015-11-25 15:23
https://www.healtheconomics.com/specialty-pharmacy/us-forum-addresses-drug-pricing-innovation-access-and-affordability60%Hourly2015-11-25 14:58
https://www.healtheconomics.com/industry-news/obama-health-chief-speaks-out-against-high-drug-prices60%Hourly2015-11-25 14:13
https://www.healtheconomics.com/industry-news/infographic-compliance-rates-for-us-childhood-vaccinations60%Hourly2015-11-25 14:01
https://www.healtheconomics.com/specialty-pharmacy/harvard-pilgrimamgen-exclusive-deal-on-repatha60%Hourly2015-11-24 13:50
https://www.healtheconomics.com/specialty-pharmacy/how-radical-are-we-willing-to-get-to-solve-drug-pricing60%Hourly2015-11-24 13:34
https://www.healtheconomics.com/comparative-effectiveness/icer-report-to-review-approaches-to-palliative-care60%Hourly2015-11-24 13:10
https://www.healtheconomics.com/specialty-pharmacy/obama-forum-discusses-pharmaceutical-pricing60%Hourly2015-11-24 12:45
https://www.healtheconomics.com/industry-news/call-for-abstracts-ispor-21st-annual-international-meeting60%Hourly2015-11-24 12:24
https://www.healtheconomics.com/fellowships/afpe-call-for-applications-now-open60%Hourly2015-11-20 23:35
https://www.healtheconomics.com/industry-news/key-findings-of-the-global-medicines-use-in-2020-report60%Hourly2015-11-20 21:13
https://www.healtheconomics.com/specialty-pharmacy/amcp-poster-abstract-submission-site-now-open60%Hourly2015-11-20 20:32
https://www.healtheconomics.com/industry-news/recap-of-the-namcp-fall-managed-care-forum60%Hourly2015-11-20 20:11
https://www.healtheconomics.com/industry-news/can-the-u-s-find-a-cure-for-financial-toxicity60%Hourly2015-11-20 19:27
https://www.healtheconomics.com/industry-news/how-industry-is-trying-to-fight-drug-prices60%Hourly2015-11-20 06:52
https://www.healtheconomics.com/uncategorized/who-are-the-big-players-measuring-prescription-drug-value60%Hourly2015-11-20 05:46
https://www.healtheconomics.com/comparative-effectiveness/which-drugs-will-the-icer-review-in-201660%Hourly2015-11-20 00:29
https://www.healtheconomics.com/industry-news/kadcyla-price-too-high-for-nice-recommendation60%Hourly2015-11-19 02:52
https://www.healtheconomics.com/industry-news/why-are-most-published-research-findings-false60%Hourly2015-11-19 02:21
https://www.healtheconomics.com/health-reform/as-washington-targets-drug-prices-will-payers-or-pharma-be-to-blame60%Hourly2015-11-19 01:20
https://www.healtheconomics.com/industry-news/doctors-vote-for-ban-on-drug-ads60%Hourly2015-11-19 01:47
https://www.healtheconomics.com/industry-news/who-has-amcp-appointed-as-new-executive-director60%Hourly2015-11-18 18:36
https://www.healtheconomics.com/ebm/download-advancing-evidence-based-decision-making-toolkit60%Hourly2015-11-18 13:49
https://www.healtheconomics.com/industry-news/can-experimental-studies-be-more-like-the-real-world60%Hourly2015-11-17 20:56
https://www.healtheconomics.com/industry-news/mallinckrodt-a-bigger-offender-than-valeant60%Hourly2015-11-17 20:29
https://www.healtheconomics.com/ebm/leverage-your-end-of-year-budget-with-doctor-evidence60%Hourly2015-11-17 19:53
https://www.healtheconomics.com/specialty-pharmacy/u-s-drug-benefit-managers-cutting-off-specialty-pharmacies60%Hourly2015-11-17 19:43
https://www.healtheconomics.com/white-papers/download-taking-on-the-pharma-pricing-challenge60%Hourly2018-01-22 18:17
https://www.healtheconomics.com/industry-news/heor-what-marketing-scientists-and-the-c-suite-need-to-know60%Hourly2015-11-16 18:08
https://www.healtheconomics.com/specialty-pharmacy/avella-honored-with-corporate-excellence-awards60%Hourly2015-11-16 17:38
https://www.healtheconomics.com/health-reform/how-are-drugmakers-responding-to-the-pricing-debate60%Hourly2015-11-16 16:56
https://www.healtheconomics.com/industry-news/how-is-advera-using-the-foia-on-the-fda60%Hourly2015-11-16 16:00
https://www.healtheconomics.com/biosimilars/what-will-formulary-committees-do-with-biosimilars60%Hourly2015-11-16 14:52
https://www.healtheconomics.com/government/which-drugmakers-are-in-the-senate-hot-seat60%Hourly2015-11-13 13:40
https://www.healtheconomics.com/industry-news/physicians-payers-and-government-increasing-concerned-over-pricing60%Hourly2015-11-13 12:40
https://www.healtheconomics.com/syndicated-reports/download-risk-based-monitoring-market-assessment60%Hourly2017-06-20 02:02
https://www.healtheconomics.com/industry-news/why-is-medicare-paying-so-much-for-this-old-drug-with-questionable-effectiveness60%Hourly2015-11-11 17:12
https://www.healtheconomics.com/ebm/how-can-systematic-reviews-reduce-waste-in-research60%Hourly2015-11-11 16:30
https://www.healtheconomics.com/ebm/5-essential-principles-for-understanding-analytics60%Hourly2015-11-11 16:18
https://www.healtheconomics.com/industry-news/agents-of-change-exclusive-interview-with-david-epstein60%Hourly2015-11-11 16:03
https://www.healtheconomics.com/industry-news/confused-by-drug-pricing-in-the-u-s60%Hourly2015-11-11 13:19
https://www.healtheconomics.com/industry-news/biologics-biosimilars-collective-intelligence-consortium60%Hourly2015-11-11 01:13
https://www.healtheconomics.com/industry-news/tomorrows-msls-evolving-for-a-new-healthcare-landscape60%Hourly2015-11-10 18:06
https://www.healtheconomics.com/industry-news/all-meat-good-in-moderation60%Hourly2015-11-10 16:31
https://www.healtheconomics.com/industry-news/how-do-you-protect-yourself-from-over-medicalization60%Hourly2015-11-10 15:37
https://www.healtheconomics.com/industry-news/will-california-see-drug-price-referendum-on-the-ballot60%Hourly2015-11-10 13:27
https://www.healtheconomics.com/industry-news/harvard-pilgrim-to-cover-amgens-repatha-in-pay-for-performance-agreement60%Hourly2015-11-09 20:39
https://www.healtheconomics.com/industry-news/merck-and-lilly-pricing-under-investigation-in-u-s60%Hourly2015-11-09 20:24
https://www.healtheconomics.com/patient-reported-outcomes-pro/how-do-companies-decide-on-pros-delivery-mechanisms60%Hourly2017-06-20 02:06
https://www.healtheconomics.com/industry-news/how-does-the-public-value-end-of-life-care60%Hourly2015-11-09 14:33
https://www.healtheconomics.com/comparative-effectiveness/eyeforpharmas-evidence-value-strategy-dossier60%Hourly2015-11-09 13:36
https://www.healtheconomics.com/industry-news/ema-explains-exceptions-to-trial-transparency60%Hourly2015-11-09 13:24
https://www.healtheconomics.com/comparative-effectiveness/dont-miss-xcenda-at-ispor-this-week60%Hourly2015-11-09 13:07
https://www.healtheconomics.com/industry-news/check-out-the-new-issue-of-the-evidence-forum60%Hourly2015-11-06 15:49
https://www.healtheconomics.com/syndicated-reports/orphan-drug-report-2014-download60%Hourly2017-06-20 02:07
https://www.healtheconomics.com/specialty-pharmacy/turing-competitor-offers-1-pill-alternative60%Hourly2015-11-06 14:18
https://www.healtheconomics.com/specialty-pharmacy/fda-warns-abbvies-hep-c-could-cause-serious-liver-injury60%Hourly2015-11-09 20:07
https://www.healtheconomics.com/industry-news/fda-eases-intended-use-enforcement-knowledge-of-off-label-use-okay60%Hourly2015-11-06 13:23
https://www.healtheconomics.com/industry-news/take-a-look-at-the-new-ispor-vision-202060%Hourly2015-11-06 13:01
https://www.healtheconomics.com/industry-news/top-five-reasons-to-attend-2015-drug-pricing-and-reimbursement-summit60%Hourly2015-11-05 16:33
https://www.healtheconomics.com/syndicated-reports/download-evaluatepharma-orphan-drug-report-201560%Hourly2017-06-20 02:09
https://www.healtheconomics.com/industry-news/ispor-expands-leadership-team60%Hourly2015-11-05 15:49
https://www.healtheconomics.com/industry-news/is-multi-indication-pricing-possible-in-the-uk60%Hourly2015-11-05 15:11
https://www.healtheconomics.com/comparative-effectiveness/npc-comments-on-icer-value-assessment-framework60%Hourly2015-11-05 14:37
https://www.healtheconomics.com/comparative-effectiveness/why-does-evidence-from-clinical-experience-matter60%Hourly2015-11-05 13:53
https://www.healtheconomics.com/specialty-pharmacy/countersuit-draws-more-attention-to-valeant-scandal60%Hourly2015-11-04 15:23
https://www.healtheconomics.com/specialty-pharmacy/philidor-shuts-its-doors-as-pbms-pull-out60%Hourly2015-11-04 14:36
https://www.healtheconomics.com/syndicated-reports/biosimilars-regulatory-outlook60%Hourly2017-06-20 02:11
https://www.healtheconomics.com/industry-news/download-coupons-and-co-pays-executive-summary60%Hourly2015-11-04 13:54
https://www.healtheconomics.com/government/whos-really-to-blame-for-failing-insurance-cooperatives60%Hourly2015-11-03 18:33
https://www.healtheconomics.com/industry-news/why-safety-is-playing-a-big-part-in-the-hep-c-value-game60%Hourly2015-11-03 17:56
https://www.healtheconomics.com/industry-news/hta-high-on-european-agenda60%Hourly2015-11-03 18:45
https://www.healtheconomics.com/health-information-technology/is-it-ethical-to-refuse-sharing-healthcare-data60%Hourly2017-06-20 02:13
https://www.healtheconomics.com/specialty-pharmacy/valeant-to-sever-ties-with-philidor60%Hourly2015-11-03 01:54
https://www.healtheconomics.com/health-reform/the-end-of-the-nhs60%Hourly2015-11-02 23:23
https://www.healtheconomics.com/specialty-pharmacy/six-recently-approved-specialty-drugs-worth-watching60%Hourly2015-11-02 22:27
https://www.healtheconomics.com/industry-news/consultation-begins-on-new-ema-patient-access-scheme60%Hourly2015-11-02 20:53
https://www.healtheconomics.com/industry-news/can-drug-pricing-reflect-value-and-reward-innovation-in-the-us60%Hourly2015-11-02 20:37
https://www.healtheconomics.com/industry-news/the-future-of-the-managed-care-industry-in-canada60%Hourly2015-11-03 18:43
https://www.healtheconomics.com/industry-news/managed-care-analysis-in-the-u-s60%Hourly2015-11-02 12:56